TNR Gold Corp (TSX-V:TNR, OTC:TRRXF) earlier this week discussed new developments at the Los Azules copper project following the release of a feasibility study by McEwen Copper.
The company told investors that the study confirmed Los Azules as a low-cost, long-life, and high-purity copper cathode producer. Initial production is projected at over 200,000 tonnes annually in the first five years, followed by an average of 148,000 tonnes per year across a 21-year mine life.
Silver Range Resources Ltd (TSX-V:SNG, OTC:SLRRF) announced that it has started a fall exploration project at its East Goldfield property in Nye County, Nevada.
The company will conduct an airborne total magnetic field and radiometric survey over 269 line-kilometres of the property.
First Phosphate Corp. (CSE:PHOS, OTCQX:FRSPF) has noted recent volatility and increased trading volume in its shares, which has followed China’s newly announced export controls on critical materials, including lithium iron phosphate (LFP) cathode active material (CAM).
Earlier this month, China’s Ministry of Commerce introduced broad unilateral export restrictions covering rare earth elements, processed critical materials, and related technologies and equipment.
NextSource Materials Inc. (TSX:NEXT, OTCQB:NSRCF) announced that operations at its Molo Graphite Mine and shipments of its SuperFlake graphite concentrate remain unaffected by the current political situation in Madagascar.
The battery materials company said mining and processing activities at the Molo mine continue under normal conditions, with the company maintaining its regular campaign production and logistics schedules.
Protalix Biotherapeutics Inc (NYSE-A:PLX) and Chiesi Global Rare Diseases said they remain committed to advancing treatment options for Fabry disease after a European Medicines Agency committee declined to recommend approval of a new, less frequent dosing regimen for Elfabrio (pegunigalsidase alfa).
The Committee for Medicinal Products for Human Use (CHMP) issued a negative opinion on the proposed dosing schedule of 2 mg/kg every four weeks, in addition to the already approved 1 mg/kg every two weeks regimen.
Petra Diamonds Limited (LSE:PDL, OTC:PDLMF) has launched a fully underwritten 10-for-17 rights issue to raise around £18.8 million, marking the final step of its long-term refinancing strategy.
Proceeds will support general working capital as the group extends the maturity of its senior bank debt to December 2029 and its 9.75% senior secured notes to March 2030, more than 99% of noteholders have agreed to the proposed amendments under a consent solicitation process, Petra said.
Cyprium Metals Ltd (ASX:CYM, OTC:CYPMF) will seek shareholder approval at its late-November AGM to appoint Jim Simpson and Amber Banfield as non-executive directors as the company advances the phased restart of the Nifty Copper Complex in WA’s Paterson region. Current non-executive director Ross Bhappu will retire at the conclusion of the meeting.
Executive chair Matt Fifield said the proposed appointments align the board’s skills with the company’s next phase of development, following a recent capital raise and work programs aimed at initial cathode production at Nifty.
American Rare Earths Ltd (ASX:ARR, OTCQB:ARRNF) continued to strengthen the development pathway for its flagship Halleck Creek Rare Earths Project in Wyoming during the September quarter, achieving major technical milestones and securing funding for the next stage of growth.
The company ended the quarter with A$21.2 million in cash, positioning it well to advance pre-feasibility, permitting and engineering work designed to establish Halleck Creek as the next producing rare earths mine in the United States.
FireFly Metals Ltd (ASX:FFM, TSX:FFM, OTC:MNXMF) this week returned high-grade copper and gold results from the Green Bay copper-gold project in Canada. Managing director, Steve Parsons, joined Proactive to discuss.
European Lithium Ltd (ASX:EUR, OTCQB:EULIF) has sold a further 3.03 million shares in Critical Metals Corp (NASDAQ: CRML) via an off-market transaction to a single US institutional investor at US$16.50 per share, generating net proceeds of US$50 million (approximately A$76 million) for EUR.
The company says it has fielded a high volume of shareholder enquiries about the gap between its market capitalisation and the value of its stake in CRML. As at the Nasdaq close on October 16, 2025 (US$22.72), EUR’s 53,036,338 CRML shares were worth about US$1.2 billion (A$1.85 billion), or roughly A$1.23 per EUR share—well above EUR’s current market value despite recent gains in its share price. The company says it is aware of the discrepancy and is pursuing a range of strategic options to better reflect this intrinsic value. EUR adds it now holds more than $190 million in cash reserves.